| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/13/2006 | EP1699803A1 Novel compounds |
| 09/13/2006 | EP1699796A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 09/13/2006 | EP1699791A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 09/13/2006 | EP1699766A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 09/13/2006 | EP1699478A2 Treating inflammation using a biological agent that causes cells to release cytokine receptors |
| 09/13/2006 | EP1699467A1 Aminoglycoside antibiotics for use as vap-1/ssao inhibitors |
| 09/13/2006 | EP1699443A2 Pharmaceutical formulations of bisphosphonates |
| 09/13/2006 | EP1513942B1 Galactosyl isomalt, method for production and use thereof |
| 09/13/2006 | EP1497274B1 Terphenyl derivatives, preparation thereof, compositions containing same |
| 09/13/2006 | EP1485394B1 Process for isolation of eupalitin (3-o-beta-d-galactopyranoside) from boerhavia diffusa |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1360504B1 Method for screening compounds for activity in treating an osteoclast related bone disease |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | EP1267843B1 System for transporting active substances in a biological system |
| 09/13/2006 | EP1244621B1 Nitrile derivatives as cathepsin k inhibitors |
| 09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
| 09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
| 09/13/2006 | EP1087951B9 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 09/13/2006 | EP1082319B1 Benzocarbazole and indenoindole derived estrogenic agents |
| 09/13/2006 | EP0981545B1 IGFIIE/ IGFBP2 complex |
| 09/13/2006 | CN1832947A Thiazole derivatives as npy antagonists |
| 09/13/2006 | CN1832934A Benzoxazepine-based compound |
| 09/13/2006 | CN1832728A Process for producing drug ultramicroparticle and apparatus therefor |
| 09/13/2006 | CN1831001A Bone peptide extraction, prepn. method and use thereof |
| 09/13/2006 | CN1830998A Total extractives of steroid saponin, prepn. method and application thereof |
| 09/13/2006 | CN1830980A Benzofuran compound, prepn. method and application thereof |
| 09/13/2006 | CN1830485A Preparation method of anti-inflammation analgesia medicine compound bone peptide injection |
| 09/13/2006 | CN1830475A Adhesive paste for treating femur osteonecrosis and its preparation method |
| 09/13/2006 | CN1830468A Mongoline medicine adhesive paste for treating osteoarthropathy |
| 09/13/2006 | CN1830467A Medicine for treating femur osteonecrosis and its preparation method |
| 09/13/2006 | CN1830435A Oleanol type benzofuran and its glucoside applied in preparation of anti female hormone deficiency medicine |
| 09/13/2006 | CN1830430A Dichlofenas sodium slow release suppository and its preparation method |
| 09/13/2006 | CN1274713C Inhibitors of kallikrein |
| 09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 09/13/2006 | CN1274685C Benzimidazol derivatives modulate che mokine receptors |
| 09/13/2006 | CN1274676C Quinoline and quinazoline derivatives |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/13/2006 | CN1274668C Salts of nateglinide |
| 09/13/2006 | CN1274352C Plaster for treating hyperosteogeny, protrusion of interverterbral disc, arthritis and periarthritis of shoulder joint and its preparation |
| 09/13/2006 | CN1274346C Medication for treating prolapse of cervical intervertebral disc and prolapse of lumbar intervertebral disc |
| 09/13/2006 | CN1274342C Preparation for external use of Chinese traditional medicine for treating gout and preparation method |
| 09/13/2006 | CN1274319C Use of phytosterone component in Radix Rhapontici |
| 09/13/2006 | CN1274310C Paste agent of penetrating through skin for treating arthritid and preparation method |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105668 Methods and compositions utilizing quinazolinones |
| 09/12/2006 | US7105556 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 09/12/2006 | US7105541 Naphthyl compounds, intermediates, compositions, and methods of use |
| 09/12/2006 | US7105535 Such as n-{4-[4-(1,3-benzoxazol-2-yl)pyrazol-3-yl]phenyl}-n'-methyl urea; synthesis; cancer, cell proliferative disorders, viral infections, autoimmune diseases, neurodegenerative disorders |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/12/2006 | CA2241788C Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them |
| 09/08/2006 | WO2006093313A1 T cell apoptosis inducer |
| 09/08/2006 | WO2006093290A1 9-substituted-19-norvitamin d derivative |
| 09/08/2006 | WO2006093253A1 Novel cyclic compound having quinolylalkylthio group |
| 09/08/2006 | WO2006093247A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY |
| 09/08/2006 | WO2006093217A1 Composition promoting calcium absorption and utilization of the same |
| 09/08/2006 | WO2006092829A1 External plaster containing flurbiprofen |
| 09/08/2006 | WO2006092580A1 Combination therapy |
| 09/08/2006 | WO2006092233A1 Amide derivatives of hyaluronic acid in osteoarthrosis |
| 09/08/2006 | WO2006071548A3 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 09/08/2006 | CA2599544A1 Novel aminopyridine compound with syk inhibitory activity |
| 09/08/2006 | CA2598331A1 Amide derivatives of hyaluronic acid in osteoarthrosis |
| 09/07/2006 | US20060200214 Electromagnetic stimulation in patients with osteoporosis |
| 09/07/2006 | US20060199962 1-Methoxy-3-(3-methoxy-4-nitrobenzoyl)-2-methylindolizin-6-yl]carboxamide; angiogenesis inhibitors; antitumor, -carcinogenic, and metastasis agent; rheumatic diseases; antiarthritic agents; atherosclerosis; retenosis; leukemia; cardiotonic agents; imflammatory bowel disease; obesity; antidiabetic agents |
| 09/07/2006 | US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/07/2006 | US20060199832 Use of non-immunosupressive pipecolic acid derivatives for inducing chondrogenic differentiation |
| 09/07/2006 | US20060199827 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/07/2006 | US20060199825 4-Aminating a 4-chloro-2-hydroxy-3-nitrodihydroquinoline with a N-(hetero)cyclylpiperazine, and alkylating the remaining amine group in the quinoline ring to produce a 4-(4-(hetero)cyclylpiperazinyl)-3-nitro-1-alkyldihydroquinolinone |
| 09/07/2006 | US20060199820 e.g. N1-hydroxy-N2-[(4-phenoxyphenyl)sulfonyl]-D-argininamide; metallopeptidase inhibitor; antiinflammation, anticarcinogenic, antidiabetic agent; angiogenesis inhibitor; atherosclerosis, stroke, ulcer, infertility, scleroderma, endometriosis, mesothelioma |
| 09/07/2006 | US20060199795 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma |
| 09/07/2006 | US20060199787 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/07/2006 | US20060198939 Porous ceramic composite bone grafts |
| 09/07/2006 | US20060198846 Combinations for the treatment of diseases involving angiogenesis |
| 09/07/2006 | DE10038700B4 Autologe Bindegewebe, Verfahren zu ihrer Herstellung und ihre Verwendung Autologous connective tissue, processes for their preparation and their use |
| 09/06/2006 | EP1698695A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen |
| 09/06/2006 | EP1698635A1 Benzimidazole derivatives and medical uses thereof |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1698334A1 Pharmaceutically active isoindoline derivatives |
| 09/06/2006 | EP1697356A1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors |
| 09/06/2006 | EP1696925A2 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 09/06/2006 | EP1696893A1 Continuous combination therapy with selective prostaglandin ep4, receptor agonists and an estrogen for the treatment of conditions that present with low bone mass. |
| 09/06/2006 | EP1453520B1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 09/06/2006 | EP1436303B1 Pharmaceutically acceptable alendronate salts in amorphous form |
| 09/06/2006 | EP1420771B1 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1349553B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 09/06/2006 | EP1322383B9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 09/06/2006 | EP1135374B1 Benzimidazole compounds that are vitronectin receptor antagonists |
| 09/06/2006 | EP1071449B1 Use of an antagonist antibody to the inflammatory mediator oncostatin m (osm) |
| 09/06/2006 | CN1829449A Masticatable capsule and process for producing the same |
| 09/06/2006 | CN1827777A Application of osteopontin inhibitor in rheumatoid arthritis treatment |
| 09/06/2006 | CN1827646A Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/06/2006 | CN1827638A Vancomycin and nor-vancomycin derivatives and their preparation process and use |
| 09/06/2006 | CN1827635A Glycopeptide compositions |